PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
21-Aug-2020 Finding Clues to a Successful Immune Response in the T Cells of Recovered COVID-19 Patients Gladstone Institutes
21-Aug-2020 Nordic Nanovector ASA: Invitation to Second Quarter and First Half 2020 Results Presentation and Webcast Nordic Nanovector
21-Aug-2020 New Mucinex® GeoVitalPredictor (GVP) Puts Americans One Step Ahead of Cold and Flu Outbreaks Mucinex
21-Aug-2020 Glasgow dentists sign up for new Oxford University coronavirus killing technology Commonwealth Dental Practice
21-Aug-2020 GC Aesthetics to see Global Market Recovery with Ms. Fara Naomi Macias as “GCA Head of Marketing” GC Aesthetics
21-Aug-2020 GC Aesthetics announces the release of minimal-touch insertion device, HydroCone GC Aesthetics Ltd
21-Aug-2020 Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Hengrui Therapeutics, Inc. Thermo Fisher Scientific
21-Aug-2020 Oxitec Announces Landmark Approval of Florida Keys Pilot Project to Combat Mosquito that Transmits Dengue, Zika Oxitec
21-Aug-2020 Orgenesis Selects Therapeutics, Inc. as CRO to Support Development and Planned Phase 2 Clinical Study of Ranpirnase for the Treatment of External Genital Warts Orgenesis Inc.
21-Aug-2020 Helsinn Group announces AKYNZEO® injection – a new liquid IV solution – now available in the US Helsinn Group
21-Aug-2020 U.S. FDA Approves Kesimpta® (ofatumumab) in Relapsing Multiple Sclerosis Genmab A/S
21-Aug-2020 Genmab Announces Plan to Transition Arzerra® (ofatumumab) to an Oncology Access Program for Chronic Lymphocytic Leukemia Patients in the U.S. Genmab A/S
21-Aug-2020 Genmab Announces Janssen Granted U.S. FDA Approval for DARZALEX® (daratumumab) in Combination with Carfilzomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma Genmab A/S
21-Aug-2020 Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19 Pfizer and BioNTech
21-Aug-2020 Tiziana Granted a Patent on the Use of Milciclib in Combination with Tyrosine Kinase Inhibitors for Treatment of Hepatocellular Carcinoma and other Cancers Tiziana Life Sciences plc
21-Aug-2020 Imfinzi approved in Japan for the treatment of extensive-stage small cell lung cancer AstraZeneca PLC
21-Aug-2020 Cipla and Stempeutics collaborate for launch of Stempeucel®, first 'Made in India' Cell Therapy to treat Critical Limb Ischemia (CLI) Cipla
21-Aug-2020 Tecan expands presence in the United States with new distribution agreement for detection instruments and consumables Tecan
21-Aug-2020 Cipla and Stempeutics collaborate for launch of Stempeucel®, first 'Made in India' Cell Therapy to treat Critical Limb Ischemia (CLI) Cipla
20-Aug-2020 Cipla and Stempeutics collaborate for launch of Stempeucel®, first 'Made in India' Cell Therapy to treat Critical Limb Ischemia (CLI) Cipla